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Exonic splicing enhancers contribute to
the use of both 39 and 59 splice site usage
of rat b-tropomyosin pre-mRNA
MEENAKSHI SELVAKUMAR1,2 and DAVID M. HELFMAN1
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724-2208, USA
2Department of Molecular Genetics and Microbiology, State University of New York at Stony Brook,
Stony Brook, New York 11794-5222, USA
ABSTRACT
The rat b-tropomyosin gene encodes two tissue-specific isoforms that contain the internal, mutually exclusive ex-
ons 6 (nonmuscle/smooth muscle) and 7 (skeletal muscle). We previously demonstrated that the 39 splice site of
exon 6 can be activated by introducing a 9-nt polyuridine tract at its 39 splice site, or by strengthening the 59 splice
site to a U1 consensus binding site, or by joining exon 6 to the downstream common exon 8. Examination of
sequences within exons 6 and 8 revealed the presence of two purine-rich motifs in exon 6 and three purine-rich motifs
in exon 8 that could potentially represent exonic splicing enhancers (ESEs). In this report we carried out substitution
mutagenesis of these elements and show that some of them play a critical role in the splice site usage of exon 6 in
vitro and in vivo. Using UV crosslinking, we have identified SF2/ASF as one of the cellular factors that binds to these
motifs. Furthermore, we show that substrates that have mutated ESEs are blocked prior to A-complex formation,
supporting a role for SF2/ASF binding to the ESEs during the commitment step in splicing. Using pre-mRNA sub-
strates containing exons 5 through 8, we show that the ESEs within exon 6 also play a role in cooperation between
the 39 and 59 splice sites flanking this exon. The splicing of exon 6 to 8 (i.e., 59 splice site usage of exon 6) was
enhanced with pre-mRNAs containing either the polyuridine tract in the 39 splice site or consensus sequence in the
59 splice site around exon 6. We show that the ESEs in exon 6 are required for this effect. However, the ESEs are not
required when both the polyuridine and consensus splice site sequences around exon 6 were present in the same
pre-mRNA. These results support and extend the exon-definition hypothesis and demonstrate that sequences at the
39 splice site can facilitate use of a downstream 59 splice site. In addition, the data support the hypothesis that ESEs
can compensate for weak splice sites, such as those found in alternatively spliced exons, thereby providing a target
for regulation.
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INTRODUCTION
For most eukaryotic genes, pre-mRNA splicing is an
essential step in the production of functional mRNAs
that can be translated into their cognate gene product+
Splicing also serves as a versatile regulatory mecha-
nism for the posttranscriptional control of gene expres-
sion+ Through the differential splicing of introns, two or
more alternative isoforms of a protein can be produced
from the same pre-mRNA transcript+ The process of
pre-mRNA splicing is carried out by the spliceosome,
where, following the initial recognition of splice sites at
the 39 and 59 ends of exons by splicing factors, two
transesterification reactions take place, joining together
the exons with the concomitant excision of the intron+
The cis elements on the pre-mRNA are the 59 splice
site and the 39 splice site, which also include the branch
point and the polypyrimidine tract (Kramer, 1996)+ The
initial pairing of splice sites is a highly regulated pro-
cess and the various cis and trans elements that are
involved in this commitment step are still being char-
acterized+ The process of splicing must take place with
a high degree of specificity and fidelity and, in spite of
these stringent requirements, the cis elements that gov-
ern splice site usage have been found to be loosely
conserved+
The lack of conservation of splice sites in metazoan
pre-mRNAs, combined with the presence of sequences
within introns that match splice site consensus equally
if not better than the true splice sites, leads to the ques-
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tion of how the proper splice sites are chosen and paired
(reviewed in Horowitz & Krainer, 1994)+ A simple an-
swer is that the splicing machinery uses sequence in-
formation other than only the splice sites themselves to
make an accurate choice+ These sequences can either
promote or repress splice site usage+ Cis elements that
promote splice site usage can lie within intron as well
as exon sequences in the pre-mRNA+ The first obser-
vation that exon sequences and splice site proximity
play a role in splicing came from studies using model
pre-mRNA substrates (Reed & Maniatis, 1986)+ Later, it
was found that activation of a weak 39 splice site of an
alternatively spliced exon in b-tropomyosin (b-TM) pre-
mRNA requires sequences in the downstream exon
(Helfman et al+, 1988)+ Several classes of exonic splic-
ing enhancers (ESEs) have since been characterized
in different systems (reviewed in Wang et al+, 1997)+
The best characterized ESE is found in the Drosophila
doublesex (dsx) pre-mRNA where the ESE is a 13-nt
repeat element (dsxRE) and is essential for exon in-
clusion (Tian & Maniatis, 1993)+ In higher eukaryotes,
ESEs have been characterized in several systems, such
as the immunoglobulin M system, cardiac troponin T,
bovine growth hormone, and fibronection (Lavigueur
et al+, 1993; Sun et al+, 1993; Watakabe et al+, 1993;
Xu et al+, 1993)+ In many of these systems the ESEs
are enriched in purines, having a general consensus
of (GAR)n+ The initial characterization of purine-rich
ESEs was in immunoglobulin M, where it was shown
that it was necessary for upstream 39 splice site usage+
Moreover, sequences containing the purine-rich ESEs
could functionally replace the dsxRE in the Drosophila
dsx pre-mRNA (Watakabe et al+, 1993)+ In general, de-
letion or interruption of the ESEs causes skipping/
aberrant splicing of the exon from which they were
removed+
Evidence has been accumulating that SR proteins
function via direct recognition of exon sequences+ Ini-
tially, SR proteins were found to bind directly to, and be
required for, the function of purine-rich elements in the
exons of certain alternatively spliced pre-mRNAs (La-
vigueur et al+, 1993; Sun et al+, 1993; Tian & Maniatis,
1993;Ramchatesingh et al+, 1995;Yeakley et al+, 1996)+
SF2/ASF can be crosslinked to the last exon of the
bovine growth hormone, which contains a purine-rich
ESE required for removal of the upstream intron (Sun
et al+, 1993)+ SR proteins can also be UV crosslinked to
pre-mRNA in the E (early) complex (Staknis & Reed,
1994), and site-specific labeling studies indicate that
the crosslinking is to exon sequences+ Consistent with
this result, Blencowe et al+ (1994) have shown that
exon-containing splicing intermediates and products are
preferentially immunoprecipitated from splicing reac-
tions by using an antibody to SR proteins+ In addition,
exon sequences can promote U2AF binding, an effect
thought to be mediated by SR proteins (Cavaloc et al+,
1994)+
Among the various roles SR proteins play in splicing,
such as in influencing the choice between alternate
splice sites (Krainer et al+, 1990a; Fu et al+, 1992), their
function in the commitment of a pre-mRNA to splicing
is best understood (reviewed in Fu, 1995;Chabot, 1996;
Manley & Tacke, 1996; Valcarcel & Green, 1996)+ SR
proteins are detectable in the earliest pre-spliceosome
complex—the E/commitment complex+ It has been sug-
gested that SR proteins act in this capacity by recruit-
ing U1 snRNP to weak 59 splice sites+ SR proteins have
also been shown to be involved in protein–protein in-
teractions+ They have been shown to interact with
U2AF35, a component of U2AF, and with U1-70K, a
component of U1 snRNP, using the two hybrid system
and gel overlays (Wu & Maniatis, 1993)+ Since U2AF
interacts with the polypyrimidine tract at the 39 splice
site and U1 snRNP interacts with the 59 splice site, a
model has been proposed where the interaction of SR
proteins both with U1-70K and with U2AF35 can occur
across introns as well as across exons (Wu & Maniatis,
1993)+ Interactions bridging the exon support the exon
definition hypothesis+ The exon definition model is an
alternate view of splice site selection where a choice is
made that spans exons instead of introns+According to
this model, the strength of a splice site determines not
only the removal of the intron in which it is present, but
also the removal of the intron flanking the other side of
the exon, where splice site pairing is proposed to occur
across exons+ So, a weak splice site on one side of an
exon has an effect on the removal of the intron on the
other side leading to an exon skipping phenotype (Rob-
berson et al+, 1990; Berget, 1995)+
Because of the overwhelming evidence that SR pro-
teins bind to exon sequences, it was the interest of sev-
eral groups to derive a consensus binding site for each
of the SR proteins+ Using SELEX with assays based on
selection of binding sites, consensus sequences were
derived for several SR proteins+These results confirmed
that one of the high affinity binding sites of SF2/ASF, a
member of the SR protein family, was purine rich and
similar to the (GAR)n consensus (Tacke & Manley,
1995)+ More recently, the SELEX procedure was used
based on splicing activity to look for functional sites of
interaction of several SR proteins+A class of enhancers
for SF2/ASF with the consensus sequence of SRSASGA
(S represents G/C,R represents G/A) was derived using
a score matrix program (Liu et al+, 1988)+ Although de-
generate, this sequence contains the flexibility to have
a purine-rich consensus sequence+
The b-TM gene comprises 11 exons spanning 10 kb+
The pre-mRNA encoded by this gene is alternatively
spliced to yield two isoforms: a skeletal muscle-specific
isoform corresponding to skeletal muscle b-TM and a
non-muscle/smooth muscle specific isoform called TM-1
in fibroblasts or smooth muscle+ Exons 1–5, 8, and 9
are the common exons expressed in both isoforms+
Exons 7 and 10 are skeletal muscle-specific exons and
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exons 6 and 11 are the non-muscle/smooth muscle-
specific isoforms (Helfman et al+, 1986)+ We have
focused on the regulation of the mutually exclusive splic-
ing event of exons 6 and 7+ It has been shown that the
repression of the skeletal muscle-specific exon 7 in
non-muscle cells is not because of cis competition but
rather via inhibitory sequences at its 39 splice site (Helf-
man et al+, 1988, 1990; Guo et al+, 1991)+ Previous
studies of the alternative splicing of exon 6 revealed
that pre-mRNAs containing exon 5-intron 5-exon 6 (E5-
i5-E6) of the rat b-TM gene cannot be spliced by HeLa
nucelar extract in vitro+ This inability of the 39 splice site
of exon 6 to be utilized can be overcome by three
different modifications: (1) first joining exon 6 to the
downstream exon 8 (Helfman et al+, 1988), (2) intro-
ducing a 9-nt poly(U) tract upstream of the 39 splice
site of exon 6, and (3) strengthening the 59 splice site
of exon 6 to a U1 consensus binding site (Tsukahara
et al+, 1994; Fig+ 1A)+Additionally, it was seen that splic-
ing of exon 5 to exon 6 was competed by the addition
of exon 6/8 sequences and not by other sequences,
indicating the importance of these exon sequences (Tsu-
kahara et al+, 1994)+ Examination of the sequences in
exon 6 and exon 8 revealed the presence of several
purine-rich motifs+ Two are present in exon 6 and three
in exon 8 of the general consensus GARGARGAR
(Fig+ 1B)+ The purine-rich sequences described here
are reminiscent of those characterized in the cardiac
troponin T gene (Xu et al+, 1993), which have been
shown to act as ESEs+
In this report, we show that only certain motifs act as
ESEs and contribute to downstream splice site usage
in vitro and in vivo and that they exert their effect be-
fore the A-complex stage of spliceosome assembly+
We also show through UV crosslinking that SF2/ASF
can interact with these sequences+ Furthermore, we
show that the sequences in exon 6 play an important
role for both 39 and 59 splice site usage+ Our data in-
volving sequences in and around exon 6 provide an
insight into the exon definition model+
FIGURE 1. Internal exons of b-TM and reg-
ulation of their splicing+ A: Activation of ex-
ons in their respective tissue types are shown
by arrows+ Exons 6 and 7 are the alterna-
tively spliced exons being present in b-TM
mRNA in smooth/nonmuscle cells and skel-
etal muscle cells, respectively+ B: Organiza-
tion and localization of ESEs in exons 6 and
8+ Representation of ESEs in exons 6 and 8
are shown as the striped bars within the
exon+ Two motifs, 6-1 and 6-2, are present
in exon 6 and three motifs, 8-1, 8-2, and 8-3,
are present in exon 8+ The general con-
sensus of the motifs is GARGARGAR and
mutagenesis of the motifs was made by sub-
stituting TCT for the first, fifth, and seventh
nucleotides, respectively, changing the motif
to TARGCRTAR+ Mutagenesis was done
using oligonucleotides and PCR+
380 M. Selvakumar and D.M. Helfman
 Cold Spring Harbor Laboratory Press on April 30, 2014 - Published by rnajournal.cshlp.orgDownloaded from 
RESULTS
Several purine-rich motifs are present
within exons 6 and 8
Previous observations revealed a role for sequences
within exons 6 and 8 with respect to 39 splice site usage
of exon 6 (Helfman et al+, 1988; Tsukahara et al+, 1994)+
Inspection of sequences in exons 6 and 8 revealed the
presence of five purine-rich motifs (Fig+ 1B) similar to
ESEs characterized in other systems (Lavigueur et al+,
1993; Sun et al+, 1993; Watakabe et al+, 1993; Xu et al+,
1993)+ Two of the motifs are present in exon 6, termed
6-1 and 6-2, and three of the motifs are in exon 8,
termed 8-1, 8-2, and 8-3+ We directed our studies to
these purine-rich motifs to determine if they play a func-
tional role in splice site usage+ To disrupt the purine
content of the motifs, three Pu r Py substitutions were
made in each repeat (see Fig+ 1B for details of substi-
tutions)+
Certain purine-rich motifs in exons 6
and 8 act as exonic splicing enhancers
Splicing efficiency of the different pre-mRNAs, mutated
at individual purine-rich motifs, was analyzed using an
in vitro splicing assay (Fig+ 2)+ Mutations in motifs 6-1,
6-2, and 8-2 are the most deleterious for the removal of
intron 5 (Fig+ 2, lanes 2, 3, and 5)+ Furthermore, when
mutations to motifs 6-1, 6-2, and 8-2 are introduced
together, they abolish 39 splice site usage completely
(Fig+ 3, lane 10)+ Motif 8-1 contributes the least to 39
splice site usage+ This is not surprising, as this element
contains the sequence AAAGAAGAC and is the most
divergent from the canonical GARGARGAR repeats,
as seen in Figure 1B+ These results demonstrate that
only some of the purine-rich motifs within exons 6 and
8 are required and they act in combination with each
other+ So, in spite of the motifs having a similar con-
sensus, the fact that certain motifs are required for 39
splice site activation implies a dependence on context
for the purine-rich motifs to have an effect on 39 splice
site usage+
Wild-type exon 6/8 sequences can inhibit
splicing of exon 5 to exon 6
ESEs have been shown to play a role in the initial
commitment to splicing of a pre-mRNA in other sys-
tems+ Since the purine-rich ESEs in exons 6 and 8 are
essential for 39 splice site usage of exon 6, we hypoth-
esized that they were recognized by a nuclear factor
that acted at the E/commitment complex step+ To ad-
dress this hypothesis, a splicing-competition assay was
carried out where wild-type and mutant competitor RNAs
were preincubated with nuclear extract prior to the ad-
dition of ATP/creatine phosphate (CP; ATP is required
for A-complex formation but not for E-complex forma-
tion) and substrate RNA+ The RNA competitors used in
these studies spanned exons 6 and 8 (132 nt), but
lacked the splice sites at the 59 and 39 ends of the
joined exons+ A competitor RNA that contained muta-
tions (see Fig+ 1B for details) in the three ESE motifs,
6-1, 6-2, and 8-2, was also constructed because our
previous results (Fig+ 2) showed that these three motifs
had the strongest enhancer activity+ A range of 10- to
50-fold molar excess of RNA competitor was used+ Ad-
dition of increasing amounts of the wild-type competitor
inhibits the splicing of exon 5 to exon 6, as seen by the
decrease of product mRNA (Fig+ 3, lanes 2–5)+ How-
ever, addition of mutant competitor has a minimal effect
on abolishing the splicing of exon 5 to exon 6 (Fig+ 3,
lanes 6–9)+ These results indicate that the purine-rich
motifs in exons 6 and 8 are essential for 39 splice site
activation of exon 6+
In the case of the pre-mRNA containing the mutated
ESEs (p4d55 6-1/2, 8-2) the possibility exists that a
silencer element was inadvertently created in the pro-
cess of mutating the ESEs, which could then inhibit
FIGURE 2. Differences among ESEs on 39 splice site usage+ Wild-
type and the different mutant pre-mRNAs were analyzed in an in vitro
splicing assay+ Substrates were spliced using HeLa nulear extract+
p4d55 is the pre-mRNA that spans E5-i5-E6-E8+ Lane 1: p4d55 wild-
type pre-mRNA; lane 2: p4d55 6-1; lane 3: p4d55 6-2; lane 4:
p4d55 8-1; lane 5: p4d55 8-2; lane 6: p4d55 8-3+
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splicing through the binding of a splicing repressor+ To
resolve this issue, a competition experiment was car-
ried out using wild-type and mutant competitor RNA in
a splicing reaction containing the mutant pre-mRNA+ If
a repressor element was central to the mutant pre-
mRNA’s block of 39 splice site usage, then addition of
mutant competitor should relieve that inhibition by ti-
trating away the inhibitory factor and allowing 39 splice
site usage+ As seen in Figure 3, lanes 15–18, however,
addition of the mutant RNA competitor does not pro-
mote splicing of the mutant pre-mRNA+Collectively from
these results, we conclude that wild-type exon se-
quences block splicing of the wild-type substrate by
titrating away one or more nuclear factors that bind to
the purine-rich ESEs, whereas the mutant pre-mRNA’s
inability to be spliced lies not in its repression via a
nuclear factor, but in its inefficient recognition by such
positive-acting factor(s)+
ESEs in b-TM act before A-complex formation
The initial splice site recognition and commitment to
splicing is thought to be mediated by a number of fac-
tors+ A pre-mRNA is committed to splicing when its
processing cannot be contested by the addition of ex-
cess RNA+ This commitment step occurs in the E com-
plex that forms subsequent to the H (hnRNP) complex
and prior to A-complex formation (Reed & Palandjian,
1997)+ These complexes can be visualized in a
spliceosome-assembly assay in which labeled pre-
mRNAs are incubated under splicing conditions and
electrophoresed through a native gel+ This assay has
been well characterized using the adenovirus pre-
mRNA substrate (Ad-1; Konarska & Sharp, 1986), and
we used it to test the hypothesis that the observed
ESE-mediated effect occured prior to A-complex for-
mation, in the absence of ATP, as suggested by the
previous experiments+ Figure 4, lanes 1, 11, and 21,
show the migration of the Ad-1, p4d55 mutant, and p4
wild-type (wt) pre-mRNAs alone+ Upon addition of nu-
clear extract, ATP and CP, the three pre-mRNAs as-
sembled into H complex at zero time point (Fig+ 4,
lanes 2, 12, and 22)+ This complex is formed by both
the specific and nonspecific binding of hnRNP proteins
onto pre-mRNAs+ The Ad-1 pre-mRNA assembled ef-
ficiently into A and then into B and C complexes with
increasing time at 30 8C (Fig+ 4, lanes 3 and 4)+ The
b-TM p4d55 wild-type pre-mRNA assembled efficiently
into A complex (Fig+ 4, lanes 23 and 24) but B- and
C-complex assembly is inefficient compared to Ad-1
pre-mRNA-mediated complex assembly+ However, the
mutant p4d55 pre-mRNA did not assemble into A com-
plex and was blocked at H-complex formation (Fig+ 4,
lanes 13 and 14)+ These results imply that the ineffi-
ciency of mutant pre-mRNA splicing lies in its inability
to form a commitment complex+
To further assess the role of b-TM exon 6/8 se-
quences, we tested the ability of the wild-type and mu-
tant exon competitors to contest A-complex formation
in the three different pre-mRNAs+ The Ad-1 pre-mRNA
was not inhibited in A-complex formation by either the
wild-type (Fig+ 4, lanes 5, 6, and 7) or mutant pre-
mRNA competitors (Fig+ 4, lanes 8, 9, and 10)+ As ex-
pected, the addition of wild-type or mutant competitor
had no effect on the mutant pre-mRNA that is blocked
at H complex (Fig+ 4, lanes 15–20)+Addition of increas-
ing concentrations of the wild-type competitor (Fig+ 4,
lanes 25–27) to the wild-type pre-mRNA inhibited
A-complex formation, whereas addition of the mutant
competitor to wild-type pre-mRNA blocked A-complex
formation only at high concentrations+ These results
complement the splicing competition assay (Fig+ 3) and
indicate that competition by these purine-rich exon se-
quences is specific for the b-TM pre-mRNAs+
UV crosslinking of sequences in exons 6/8
reveals the binding of an ;30 kDa protein
Because it was clear that ESEs play a role in 39 splice
site activation, presumably via the interaction with a
nuclear factor, we used UV crosslinking to assay for
proteins that interact with these sequences+ This type
of assay is used routinely to identify factor(s) that bind/
interact specifically with nucleic acid probes+ The probes
used for UV crosslinking were the same as that used
for the competition experiments, that is, wild-type or
mutant sequences (mutated at 6-1, 6-2, 8-2) spanning
FIGURE 3. Splicing of p4d55 pre-mRNA is competed by wild type
but not mutant exon sequences+ Splicing competition was carried out
by incubation of exon sequences with nuclear extract at 30 8C for
20 min+ ATP/CP-containing mix and the indicated pre-mRNAs were
then added and splicing was allowed to continue for an additional
100 min+ Lanes 2–5 (10 ng, 50 ng, 100 ng, and 250 ng, respectively)
and 11–14 (10 ng, 50 ng, 100 ng, and 250 ng, respectively): preincu-
bation of wild-type exon sequence competitor (wt) with nuclear ex-
tract+ Lanes 6–9 (10 ng, 50 ng, 100 ng, and 250 ng, respectively) and
15–18 (10 ng, 50 ng, 100 ng, and 250 ng, respectively): preincuba-
tion of mutant exon sequence competitor (mt) that had substitutions
of ESEs 6-1, 6-2, and 8-2 with nuclear extract+ Lanes 1–9: wild type
pre-mRNA (p4d55*)+ Lanes 10–18: mutant pre-mRNA (p4d55 6-1,
6-2, 8-2*)+
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exons 6 and 8+ The labeled probes were incubated
with nuclear extract and subjected to UV crosslinking,
after which they were treated with RNase before being
electrophoresed in an SDS-PAGE system+ Several dif-
ferences in binding ability were observed between wild-
type and mutant probes+ There was a significant
difference in the affinities between the probes to a broad
band of ;33 kDa (Fig+ 5A, lanes 1 and 2)+ Our initial
studies focused on the identification of this protein(s)+
While the wild-type probe binds the lower portion of the
band with greater intensity, the mutant probe binds the
upper portion of the band with greater affinity (Fig+ 5A,
lane 1 vs+ 2)+
It has been shown in several systems that SR pro-
teins can bind to ESEs (Sun et al+, 1993; Ramchate-
singh et al+, 1995; Yeakley et al+, 1996)+ We were
interested in seeing if SR proteins or a subset of them
bind to the ESEs in exons 6 and 8+ SR proteins can be
purified in a two-step purification, namely an ammo-
nium sulfate fractionation (60–90%) followed by mag-
nesium chloride precipitation (20 mm; Zahler et al+,
1992)+ In an effort to separate the broad crosslinking
band into more discrete bands, we tested the cross-
linking abilities of these probes using different ammo-
nium sulfate fractions+ Nuclear extract was subjected
to several ammonium sulfate precipitations, that is,
0–30%, 30–60%, and 60–90%+ The 60–90% cut was
further subjected to a 20 mm MgCl2 precipitation+When
these different fractions were crosslinked to the wild-
type and mutant probes,we observed that the two ;35-
kDa crosslinking products could now be separated+ The
wild-type probe binds the 35-kDa band present in the
SR preparation (Fig+ 5A, compare lanes 9 and 10),
whereas the mutant probe binds an activity that is pre-
cipitated by a 30–60% ammonium sulfate cut (Fig+ 5A,
compare lanes 5 and 6)+ Since the only differences
between these two probes is the 3-nt substitution in
three motifs, we think that a binding site for a nuclear
factor may have been created+ Since pre-mRNA sub-
strates containing this mutation cannot be spliced, this
FIGURE 4. ESEs promote H- to A-complex formation in b-TM pre-mRNA+ Spliceosome assembly formation was analyzed
by incubating pre-mRNA with nuclear extract for indicated time points+ Then entire reaction was then loaded on a 80:1
Tris-glycine nondenaturing gel to detect complex formation+ Lanes 1–10 represent Ad-1 pre-mRNA, lanes 11–20 represent
p4d55 mutant pre-mRNA, and lanes 21–30 represent p4d55 wt pre-mRNA+ Lanes 1, 11, and 21 are Ad-1, p4d55 mutant,
and p4d55 wt pre-mRNA alone, respectively+ Lanes 2–4, 12–14, and 22–24 represent the three pre-mRNAs incubated with
nuclear extract at 0, 30, and 90 min time points+ Lanes 5–7, 15–17, and 25–27 show the effects of wild-type exon 6/8
competitor (50 ng, 100 ng, and 250 ng, respectively) on the three pre-mRNAs and lanes 8–10, 18–20, and 28–30 show the
effects of the mutant exon 6/8 competitor (50 ng, 100 ng, and 250 ng, respectively) on the different pre-mRNAs+ H,A, B, and
C represent H, A, B, and C spliceosome complexes, respectively+
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activity was not further investigated+ We do not think
that this is an inhibitory factor for reasons discussed
above (Fig+ 3)+ SF2/ASF purified from HeLa cells was
tested for its ability to crosslink wild-type and mutant
probes, and it was seen that there was binding to the
wild-type probe by SF2/ASF as compared to the mu-
tant probe (Fig+ 5B, compare lanes 3–5 with 8–10)+ We
propose that because the 39 splice site of exon 6 is
poor, SF2/ASF binds via the ESEs, thereby contribut-
ing to recognition of the splice site+
Competition by wild-type exon sequences
can be rescued by SF2/ASF
Wild-type sequences inhibit splicing of substrate p4d55
(Fig+ 3) and were able to interact with SF2/ASF
(Fig+ 5B)+ To determine if SF2/ASF was sufficient to
rescue the inhibitory effects of competition by the wild-
type sequences, competition assays were performed
as described in Figure 3+ Additional protein was added
to some of the reactions (Fig+ 6, lanes 10–18)+ Since
nuclear extract contains all the protein components
required for splicing, it could rescue splicing of p4d55
pre-mRNA(Fig+ 6, lanes 10–11)+An SR preparation also
had the ability to rescue splicing of the p4d55 substrate
in this competition assay (Fig+ 6, lanes 14–15)+ We
tested a HeLa cell-purified SF2/ASF preparation to com-
plement the UV crosslinking studies described earlier,
and we observed that SF2/ASF alone could rescue the
splicing of the p4d55 substrate (Fig+ 6, lanes 16–17),
although after UV crosslinking, other proteins were also
bound to the exon sequences+On the other hand, splic-
ing could not be rescued by the addition of S100, a
cytoplasmic fraction that lacks only SR proteins in or-
der to be splicing competent (Fig+ 6, lane 18)+ Despite
the fact that U2AF and U1 snRNP act at the E complex,
addition of a 0–60% ammonium sulfate fraction con-
taining these two factors could not rescue splicing
(Fig+ 6, lanes 12–13)+
Taken together, the spliceosome assembly,UV cross-
linking, and competition experiments demonstrate that
the ESEs bind SR proteins, most notably SF2/ASF, at
the E complex stage of splicing+ This interaction pre-
sumably occurs so that the splicing machinery is re-
cruited to an otherwise inefficiently used splice site+
These results demonstrate the specificity of the RNA–
protein interaction in the context of ESEs and SF2/ASF+
In an effort to promote the splicing of the mutant
pre-mRNA, additional SR proteins were added to the
splicing reactions of mutant substrates+ As shown in
Figure 7, lanes 2–5, addition of total SR proteins, HeLa
purified SF2, recombinant SF2, or SC35 did not acti-
vate splicing of the mutant pre-mRNA+ The same pro-
cedure was carried out using wild-type pre-mRNA to
show that increasing the concentration of protein is, in
itself, not inhibitory to splicing (Fig+ 7, lanes 7–10)+ This
indicates that merely increasing the local concentration
of SF2/ASF is not sufficient to activate splicing, but
actual interaction with exon sequences is crucial in its
ability to promote splicing+ Lanes 11–16 show splicing
FIGURE 5. SF2/ASF crosslinks specifically to wild-type exon se-
quences+ Probes were uniformly labeled using [32P]GTP, [32P]ATP,
[32P]UTP, and [32P]CTP+ Incubation of probes was carried out with
indicated proteins/fractions at 30 8C and then crosslinked under UV
light for 5 min+ Following RNase digestion, the entire reaction was
electrophoresed on an SDS-PAGE system+ A: Wild-type and mutant
exon sequences crosslink a different subset of proteins+ Wild-type
exon probe (W): lanes 1, 3, 5, 7, and 9+ Mutant exon probe (M):
lanes 2, 4, 6, 8, and 10+ Crosslinking of nuclear extract: lanes 1 and
2+ 0–30% ammonium sulfate: lanes 3 and 4+ 30–60% ammonium
sulfate: lanes 5 and 6+ 60–90% ammonium sulfate: lanes 7 and 8+
20 mM MgCl of a 60–90% ammonium sulfate precipitation: lanes 9
and 10+ B: SF2/ASF crosslinks the ESEs in exons 6 and 8+
Lanes 1–5: wild-type exon probe+ Lanes 6–10: mutant exon probe+
Lanes 1 and 6: nuclear extract+ Lanes 2 and 7: SR proteins+
Lanes 3–5 and 8–10: increasing amounts of HeLa purified SF2/ASF
(50, 100, and 200 ng)+
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of wild-type pre-mRNA in the presence of competitor+
Similar to results shown in Figure 6, SR proteins, HeLa-
purified SF2, and recombinant SF2 rescue splicing+
However, addition of SC35, an SR protein of similar
mobility to SF2, lacks the ability to rescue splicing+ This
result demonstrates a substrate specificity between SR
proteins and ESEs+
Predicted SF2/ASF binding sites correlate
with ESEs in exons 6 and 8
Specific exonic target sequences recognized by sev-
eral SR proteins under splicing conditions have been
identified using a functional SELEX approach (Liu
et al+, 1988)+ The sequences identified for SF2/ASF
were then analyzed to determine a consensus se-
quence, using the program GIBBS sampler, which was
found to be SRSASGA (S represents G or C, R repre-
sents purine)+ The defined motifs were used to gener-
ate a score matrix, according to the frequency of each
nucleotide at each position+ This score matrix was then
used to analyze the distribution of high score motifs in
exons 6 and 8 of b-TM (see Fig+ 8)+ The top panel
shows the distribution of ESE motifs detected by this
method+ The y-axis represents the strength of the ESE
motif and the x-axis represents exons 6 and 8 joined
together with exon 6 spanning nt 1–76 and exon 8
spanning nt 77–132+ The bar below this graph repre-
sents exons 6 and 8, with the purine-rich motifs ana-
lyzed in this study indicated by shaded blocks+ There is
a correlation between the GARGARGAR motifs and
the potential SF2/ASF interaction sites picked up using
the score matrix program+ Next, the sequence with mu-
tations in the purine-rich motifs (see Fig+ 1B for details)
was analyzed in the same manner, and it was seen that
the three point mutations to each motif eliminated most
of the predicted SF2/ASF interacting sites+
The fact that two completely independent approaches
gave rise to strikingly similar results indicates the rel-
FIGURE 6. Splicing of competed pre-mRNAs can be rescued by SF2/ASF+ Competitions were performed as described in
Figures 2–4 with substrate pre-mRNA spliced using 8 mL HeLA extract (10 mg/mL)+ Lane 1 represents p4d55 mutant
pre-mRNA+ Lanes 2–18 represent p4d55 wt pre-mRNA+ Lanes 4–6: increasing amounts of wt exon 6/8 sequences (50, 100,
and 250 ng, respectively) were preincubated with nuclear extract prior to the addition of ATP/CP and labeled pre-mRNA+
Lanes 7–9 represent mutant exon 6/8 sequences (50, 100, and 250 ng, respectively) preincubated with nuclear extract prior
to the addition of labeled pre-mRNA+ Lanes 10–18: 250 ng of wild-type exon sequences were preincubated with nuclear
extract prior to the addition of wild-type pre-mRNA and ATP/CP+ In addition, we added in lanes 10 and 11: NE (40 mg, 80 mg);
lanes 12 and 13, 0–60% ammonium sulfate (30 mg, 60 mg); lanes 14 and 15: total SR proteins (200 ng, 400 ng); lanes 16
and 17: HeLa purified SF2 (100 ng, 200 ng); and lane 18: S100 (70 mg)+
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evancy of these sequences to 39 splice site usage and
that SF2/ASF is involved in this process via functional
interaction+
p2p6(8/9) as a model for exon definition
The b-TM substrate p2p6(8/9) which spans exons 5
through 9 (E5-i5-E6-i6-E7-i7-E8-E9) exhibits an exon-
skipping phenotype in vitro for reasons that are un-
clear+ This substrate skips the nonmuscle exon 6 in an
in vitro splicing assay using nuclear extract prepared
from HeLa cells and is processed to an E5-E8-E9 prod-
uct+ However, when the 39 splice site of exon 6 is im-
proved to include a strong polypyrimidine tract containing
a stretch of nine uridines, p2p6(8/9)pU, the exon in-
clusion product is obtained (E5-E6-E8-E9)+ Moreover,
a splicing intermediate that utilizes the 59 splice site of
exon 6 is also seen (E5-i5-E6-E8-E9; Tsukahara et al+,
1994)+ Exon 7, being skeletal muscle-specific, is not
utilized in either substrate+ These observations are in
agreement with the exon definition hypothesis (Berget,
1995) in which a strong splice site on one side of an
exon is communicated across that exon and improves
the use of the splice site on the other side+ Because
exon 6 contains two purine-rich motifs that have been
demonstrated to act as ESEs, we were interested in
seeing if they also play a role in defining and bridging
exon 6, thereby promoting its recognition+
Inclusion of exon 6 is dependent
on exon sequences
To determine if exon sequences, in particular the purine-
rich elements in exon 6, are required for its inclusion,
we introduced the same type of mutations as described
above that disrupt the motifs+ Three purine r pyrimi-
dine substitution mutations were made in the wild-
type, p2p6(8/9) r p2p6(8/9)6-1/2, as well as in the
construct containing the strong polypyrimidine tract,
p2p6(8/9)pU r p2p6(8/9)pU6-1/2, (see Fig+ 9 for
details of mutations in and around exon 6)+ Figure 10
shows a time course experiment of splicing of these
four substrate RNAs+ Consistent with the previous
study, the wild-type pre-mRNA skips exon 6 (Fig+ 10,
lanes 1–5) and the pre-mRNA substrate with the poly U
FIGURE 7. Addition of SR proteins does not promote splicing of
mutant pre-mRNA splicing+ Lanes 1–5 represent splicing of p4d55
mutant pre-mRNA+ Lanes 6–10 represent splicing of p4d55 wt pre-
mRNA+ Lanes 11–16 represent splicing of p4d55 wt pre-mRNA in the
presence of mutant (lane 11) or wild-type competitor (lanes 12–16)+
Addition of SR proteins: 200 ng (lanes 2, 7, and 13); addition of SF2
from HeLa cells: 100 ng (lanes 3, 8, and 14); addition of recombinant
SF2: 100 ng (lanes 4, 9, and 15); and addition of SC35: 100 ng
(lanes 5, 10, and 16) to the splicing reaction+
FIGURE 8. Comparison of in vitro selected ESE motifs with ESEs in
exon 6 and exon 8+ SF2/ASF high affinity site was found to be
SRSASGA where S represents G/C and R represents G/A+ Score
matrices were built for SF2/ASF’s in vitro-selected ESE (Liu et al+
1998)+ The b-tropomyosin exon 6/8 sequence was searched with
the SF2 score matrix and the resulting scores (y axis) were plotted
against the nucleotide positions for the exons (x axis)+ Nucleotides
1–76: exon 6, nucleotides 77–132: exon 8+ The top graph shows
the results obtained for a search of SF2/ASF motifs on wild-type
exons 6/8+ The bottom graph shows the results obtained for a
search of SF2/ASf motifs on exons 6/8 mutated at 6-1, 6-2, 8-1, 8-2,
and 8-3+ Below each graph are the ESEs selected for study in this
article+
386 M. Selvakumar and D.M. Helfman
 Cold Spring Harbor Laboratory Press on April 30, 2014 - Published by rnajournal.cshlp.orgDownloaded from 
tract includes exon 6+ Moreover the polyU-containing
substrate exhibits a product that stimulates the 59 splice
site of exon 6 (E5-i5-E6-E8-E9; Fig+ 10, lanes 11–15)+
However, when the purine elements of this substrate
are disrupted (p2p6(8/9)pU6-1/2), an exon skipping
phenotype is once again predominant+ Also there is a
loss in usage of the 59 splice site of exon 6 (Fig+ 10,
lanes 16–20)+ As a control, purine-rich motifs 6-1 and
6-2 were also mutated in the wild-type construct, where
they show no change in the pattern of splicing (Fig+ 10,
lanes 6–10)+ These results show that the purine-rich
elements within exon 6 act as ESEs and may play a
role in promoting interactions across the exon between
a strong and weak splice site+
39 and 59 splice sites’ use of exon 6
requires ESEs 6-1 and 6-2
To make analysis of 39 and 59 splice site usage easier,
pre-mRNAs derived from substrate p2p6(8/9) were con-
structed and used in in vitro splicing assays (Fig+ 11A)+
The first part focuses on exon 5 to exon 6 and the
second, exon 6 to exon 8+ Both constructs include the
splice sites around exon 6+ First we analyzed the splic-
ing of exon 5 to exon 6 in the substrate p5, which
comprises exon 5 through exon 6 plus 19 nt of intron 6,
including the 59 splice site of exon 6 (E5-i5-E6-Di6;
Fig+ 11A)+ As shown previously (Helfman et al+, 1988;
Tsukahara et al+, 1994), the wild-type substrate cannot
be spliced (Fig+ 11A, lane 1) and mutations in ESEs 6-1
and/or 6-2 show no effect (Fig+ 11A, lanes 2–4)+A polyU
mutation strengthening the polypyrimidine tract at the
39 splice site allows exon 6 to be spliced to exon 5
(p5pU; Fig+ 11A, lane 5; Tsukahara et al+, 1994)+ When
we mutated ESEs 6-1 and 6-2 in this context, however,
the ability to use the 39 splice site of exon 6 was lost,
suggesting a cooperation between the polypyrimidine
tract and the exon sequences (Fig+ 11A, lanes 6–8)+ It
was shown previously that the 39 splice site of exon 6
could also be utilized when the 59 splice site upstream
of this exon was changed to a U1 snRNA consensus
binding site (p5pCs; Fig+ 11A, lane 9; Tsukahara et al+,
1994)+ It was proposed that this occurs through an exon-
bridging mechanism+ To determine if exon sequences
are required for this interaction, mutations to ESEs 6-1
and 6-2 were made in this context+ A loss of 39 splice
site use was then observed in this substrate, indicating
the necessity of the ESEs (Fig+ 11A, lanes 10–12)+
Because we observed that ESEs 6-1 and 6-2 are re-
quired if even one of the splice sites is weak, we tested
the necessity for these exon sequences when both
splice sites were strong, that is, polyU at the 39 splice
site and U1 snRNA consensus at the 59 splice site
(p5pUCs)+ This substrate can be spliced very efficiently
and even in the context of exon mutations retains this
ability (Fig+ 11A, compare lane 13 with lanes 14–16),
suggesting an alternative mechanism that bypasses
ESEs 6-1 and 6-2+
A similar set of experiments was performed to ana-
lyze the use of the 59 splice site of exon 6 (Fig+ 11B)+
Substrates used spanned a part of intron 5, including
the 39 splice site of exon 6, through exon 9 (Di5-E6-i6-
E7-i7-E8-E9) and are called Dp2p6(8/9) or its deriva-
tives pU and Cs+ The 59 splice site of exon 6, although
suboptimal, is still functional, as seen by the splicing of
exon 6 to exon 8 (Fig+ 11B, lanes 1,2)+ When the purine
motifs were mutated in this context, Dp2p6(8/9)6-1/
FIGURE 9. Mutations to the sequences in and around exon 6+ Only
the sequences targeted for substitutions are shown+ Arrows pointing
down are down-regulating substitutions and arrows pointing up are
splice site strengthening substitutions+ pU: mutations to the poly-
pyrimidine tract at the 39 splice site of exon 6, substituting to a stretch
of nine uridine residues+ Cs: mutations to the 59 splice site of exon 6,
converting it to an exact complement of the U1 snRNA+ 6-1 and 6-2
are the mutations within exon 6 disrupting the purine stretch with
pyrimidine residues+
FIGURE 10. ESEs are required for exon 6 inclusion+ Time course
(0, 30, 60, 90, and 120 min) of splicing of the p2p6(8/9) substrate in
HeLa nuclear extract+ 6-1/2: mutations to ESEs 6-1 and 6-2 in
exon 6+ pU: substitutions in polypyrimidine tract at the 39 splice site
of exon 6+ Lanes 1–5: wt; lanes 6–10: 6-1/2; lanes 11–15: Pu;
lanes 16–20: pU6-1/2+ Products and intermediates are indicated on
the right+
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6-2, there was no usage of the 59 splice site (Fig+ 11B,
lanes 3,4)+ The presence of a strong 39 splice site
upstream of this splice site, Dp2p6(8/9)pU, shows
some improvement of 59 splice site usage (Fig+ 11B,
lanes 5,6)+ However, this splicing event is also depen-
dent on the presence of purine-rich motifs 6-1 and 6-2
(Fig+ 11B, lanes 7,8)+When the 59 splice site is improved
to a consensus sequence, Dp2p6(8/9)Cs, it markedly
improves 59 splice site usage but it is also sensitive to
the nature of the exon sequences (Fig+ 11B, compare
lanes 9,10 vs+ 11,12)+ When both the splice sites are
strong, Dp2p6(8/9)pUCs, however, there is no longer a
dependence on purine-rich motifs 6-1 and 6-2 (Fig+ 11B,
compare lanes 13,14 vs+ 15,16)+
This result complements the data obtained on the 39
splice site usage of exon 6, suggesting that when one
or both splice sites around an exon are weak, then the
presence of ESEs within the exon promote splicing+
However, when both the splice sites are strong, then
the ESEs are redundant and a different mechanism is
utilized for splice site usage+
ESEs are required for exon 6 inclusion in vivo
To correlate ESEs’ requirement in vitro with an in vivo
situation, we employed a transient transfection assay+
Minigene b-TM constructs had been used previously
for in vivo transfection experiments (Helfman et al+, 1988,
1990; Guo et al+, 1991; Guo & Helfman, 1993; Caceres
et al+, 1994)+ These constructs have an SV40 promoter
and a 59 UTR followed by genomic sequences span-
ning exons 5–9+ We had shown previously using RT-
PCR that the SV40 p2 constructs undergo two types of
processing events in vivo, as exon 6 is only partially
included in nonmuscle cells while exon 7 is always
suppressed+
The same type of point mutations as previously de-
scribed (i+e+, to motifs 6-1 and 6-2) were introduced in
exon 6 as described in the in vitro system, and the
effect of these mutations was tested by transfecting
plasmids containing the minigenes (Fig+ 12) in HeLa
and 293 cells+ Cytoplasmic mRNA was harvested fol-
lowed by RT-PCR using reverse primers specific for
exons 5 and 9+ To prevent amplification of endogenous
b-TM mRNA, the forward primer was complementary
to the 59 UTR of SV40+ We observe that the ESE mu-
tations in exon 6, individually or in combination, abolish
exon inclusion completely (Fig+ 12, right panel, lanes 4,
7, 8, and 9) compared to the wild-type minigene
(Fig+ 12, right panel, lanes 3 and 6), which showed both
the exon-inclusion as well as exon-skipping products+
Since exon 7 is the same size as exon 6, we needed to
rule out aberrant exon usage+ A unique Nco1 site is
present within exon 6+ Digestion of the RT-PCR prod-
ucts with Nco1 (right panel) confirms exon 6 usage+
The above results confirm the results obtained from
the in vitro splicing assay system described above and
demonstrate a role for the ESEs in vitro as well as in vivo+
DISCUSSION
Previous studies revealed that splicing of b-TM pre-
mRNA requires an ordered pathway of splicing in which
exon 6 must first be joined to exon 8 for activation of
the 39 splice site of exon 6 (Helfman et al+, 1988)+ Those
FIGURE 11. A: ESEs are required for 39 splice site usage+ Sub-
strates comprising exon 5, intron 5, exon 6, and 19 nt at the 59 splice
of exon 6 were used+ Intron indicates wt, polyU at 39 splice site, Cs
at 59 splice site, or both polyU and Cs+ Exon indicates wt or mutations
at ESE 6-1, 6-2, or both 6-1 and 6-2+ Lanes 1–4: wt alone or with
mutations in ESEs; lanes 5–8: pU alone or with mutations in ESEs;
lanes 9–12: Cs alone or with mutations in ESEs; lanes 13–16: pUCs
alone or with mutations in ESEs+ B: ESEs are required for 59 splice
site usage+ Substrates comprising the 39 end of intron 5, exon 6,
intron 6, exon 7, intron 7, exon 8, and exon 9+ Nomenclature is the
same as in Figures 4 and 5+ Lanes 1–4: wt alone or with mutations
in ESEs; lanes 5–8: pU alone or with mutations in ESEs; lanes 9–12:
Cs alone or with mutations in ESEs; lanes 13–16: pUCs alone or with
mutations in ESEs+
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studies suggest that sequences within exon 8 contain
an important determinant for splice site usage+ Inspec-
tion of the sequences within exon 8, as well as exon 6,
reveals the presence of several purine-rich motifs+ Mo-
tifs similar to these have been shown in other systems,
including immunoglobulin, troponin T, and growth hor-
mone to act as ESEs (Lavigueur et al+, 1993; Sun et al+,
1993; Watakabe et al+, 1993; Xu et al+, 1993)+ To de-
termine if these elements play a functional role in splice
site use, each element was individually mutated and
analyzed for its effect+ The present studies demon-
strate that in addition to sequences within exon 8, se-
quences in the alternatively spliced exon 6 also play a
critical role in the use of this exon+Although both purine-
rich elements in exon 6 were essential for splice site
usage, only one of the three purine-rich elements in
exon 8 was required for activation of the 39 splice site
of exon 6 using a substrate that contained all of exon 8
joined to exon 6 (Fig+ 2)+
Conservation and cooperation among ESEs
From work done in the Drosophila dsx system, it has
been shown that ESEs act not in a synergistic manner,
but rather in an additive manner (Lynch & Maniatis,
1995, 1996; Hertel & Maniatis, 1998)+ That is, the pres-
ence of multiple motifs acts to increase the possibilities
of SR protein interaction promoting splice site usage
and that these motifs do not interact with each other+ In
the case of b-TM pre-mRNAs, mutation of any one of
the three motifs (6-1, 6-2, or 8-2), reduces 39 splice site
usage, and mutating all three of them abolishes 39 splice
site usage, suggesting that these motifs may interact
with each other to build a higher order complex that
then allows 39 splice site usage+ Also, when a third
purine-rich element was added in exon 6 in the E5-
i5-E6 context, it did not activate 39 splice site usage
(data not shown), suggesting that the context in which
the purine-rich motif is present is critical and not merely
its presence within the exon+
Interestingly, it was previously found that the splicing
of exon 6 to exon 8 required at least the first 26 nt of
exon 8 (Helfman et al+, 1988)+ Those studies show that
this is not a length requirement, as addition of up to
200 nt of intronic sequences downstream of exon 6
does not activate its 39 splice site+ Exon sequences,
specifically sequences in exons 6 and 8, were shown
to compensate for the weak 39 splice site+ In the stud-
ies presented here, we show that mutations in the
purine-rich motif at the 59 end of exon 8, that is, 8-1
(which lies within the first 26 nt), did not abolish splice
site usage, suggesting that an additional cis-acting el-
ement might be present in this region+A sequence align-
ment of b-TM genes from rat, human, and chicken
FIGURE 12. ESEs in exon 6 are required for its inclusion in vivo+ A: Parental plasmid used for transfections+ Mutations were
made to the ESEs in exon 6+ The arrows represent primers used for subsequent RT-PCR analysis+ Nco1 is the restriction
site present in exon 6 that is used to confirm its presence+ B: Lanes 1–4: HeLa cells; lanes 5–9: 293 cells+ Plasmid
transfections: control—vector alone without the minigene (lanes 1,5); Mock—no plasmid (lane 2); Wt (lanes 3,6); 6-1
(lane 7); 6-2 (lane 8); and 6-1/2 (lanes 4,9)+ The panel on the right represents the results of digesting the products obtained
with Nco1 to confirm the presence of exon 6+
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shows that in addition to the purine-rich motifs, the
pyrimidine-rich region at the 59 end of exon 8 is highly
conserved+ This pyrimidine-rich sequence at the 59 end
of exon 8 might represent a novel element and the
situation may be reminiscent of the Drosophila dsx gene,
where six 13-nt repeat pyrimidine-rich ESEs inter-
spersed by a purine-rich ESE (PRE) are present+ In
chicken b-TM the regulation of exon 6 is via a down-
stream pyrimidine-rich intronic enhancer, and activa-
tion is mediated through the interaction with SF2/ASF
(Gallego et al+, 1996, 1997)+ Such an intronic element
is absent in rat b-TM+ Moreover, as discussed above,
downstream exon sequences and not downstream in-
tron sequences are required for 39 splice site activation
of exon 6 (Helfman et al+, 1988)+ Thus, although there
is almost full conservation of exonic sequences, the
mechanism of splicing regulation may not be fully con-
served between species+
SR proteins, ESEs, and the
commitment to splicing
Since SR proteins have been proposed to play various
roles in pre-mRNA splicing, including the sequence spe-
cific interaction with the substrate, it has been of spe-
cial interest to predict these sequences using SELEX
(Tuerk & Gold, 1990)+With this method, and using RNA–
protein binding assays, consensus sequences have
been proposed to be the binding site for each SR pro-
tein+ SF2/ASF has been shown to bind to a consensus
sequence that is enriched in purine residues and to
have a general sequence similar to that of the purine-
rich motifs of exons 6 and 8 (Tacke & Manley, 1995;
Tacke et al+, 1997)+Using SELEX combined with a func-
tional assay, Liu et al+ (1998) carried out a search for
ESE motifs specific for different SR proteins+ This
method is different from previous SELEX approaches,
as the mode of interaction is based on function rather
than binding+ The consensus motif for SF2/ASF was
found to be SRSASGA and prediction of these motifs in
exons 6 and 7 coincides with functional sites charac-
terized in this study (Fig+ 7)+ Moreover exon sequences
found with mutated purine-rich motifs when analyzed
by the program developed by Liu et al+ showed an
almost complete loss of predicted SF2/ASF high-score
motifs, which correlates with the UV-crosslinking data
presented in this report (see Fig+ 5B)+ Although the
program predicts several sites for SF2/ASF interaction,
only some of them are effective in 39 splice site usage
of exon 6 as shown by the data presented here, sug-
gesting that the sequence by itself is not sufficient, but
that context and/or positional information may also play
a role in splice site selection+
We observe that SR proteins, in particular SF2/ASF,
interacts with the purine-rich elements in exon 6 during
the commitment complex+ Thus, the binding of SR pro-
teins to sequences contained within exons 6 and 8
contributes to alternative splice site selection+ It has
been demonstrated that when the b-TM SV40 p2 plas-
mid, which shows partial skipping of exon 6 in vivo, is
cotransfected with an SF2/ASF expression plasmid,
the equilibrium is shifted toward an exon-inclusion phe-
notype (Caceres et al+, 1994)+ hnRNP proteins coat a
newly synthesized transcript in both a specific and non-
specific manner, and some of these interactions play a
role in alternative splice site selection+ For example,
some hnRNP proteins, such as hnRNP A1, can antag-
onize the actions of SR proteins, such as SF2/ASF, on
alternative 59 splice sites+ In this regard it is worth not-
ing that hnRNP A1 had no effect on alternative 59 splice
site usage of b-TM pre-mRNAS in vitro (Mayeda et al+,
1993)+ In cardiac troponin T, it has recently been shown
that the conserved hnRNP protein, CUG-binding pro-
tein, was found to bind to the CUG repeats within the
muscle-specific splicing enhancers and regulate its al-
ternative splicing (Philips et al+, 1998)+ hnRNP A1 has
been shown to selectively interact with certain SR pro-
teins through its gly-rich domain (Cartegni at el+, 1996)+
It is not known if exon 6 of b-TM is regulated in skeletal
muscle via factors that affect the binding of SF2/ASF to
the purine-rich motifs in exon 6+ Analysis of the tissue
distribution of several SR proteins showed that SF2/
ASF levels are lower in skeletal muscle cells (Zahler
et al+, 1993; Hanamura et al+, 1998)+ This may serve as
a potential mode of regulation for exon 6 repression in
this cell type+ Other modes of regulation include the
local concentration, as SR proteins are known to local-
ize to speckles within the nucleus (Spector et al+, 1991),
or the state of phosphorylation of these proteins (Mer-
moud et al+, 1994)+
Regulation through cell type-specific
splicing factors
Using the Drosophila dsx pre-mRNA, it was shown that
SR proteins act in the commitment complex along with
Tra/Tra2 (Tian & Maniatis, 1993)+Recently, it was shown
that two human homologs of Tra2, hTra2a and hTra2b,
bind to purine-rich ESEs such as the GAR elements,
and although they are not necessary for constitutive
splicing, they are required for enhancer-dependent splic-
ing (Tacke et al+, 1998)+ It is thought that high concen-
trations of SF2/ASF can compensate for physiological
concentrations of the hTra2 proteins, and that hTra2
may act by recruiting SR proteins to the enhancer+ It
was previously seen that the splicing of pre-mRNAs
containing E5-i5-E6-E8 (p4d55) was not supported by
S100 1 SR proteins alone, but also required the addi-
tion of 40–60% ammonium sulfate to activate the 39
splice site of exon 6 (Tsukahara et al+, 1994)+ The iden-
tity of this additional component in the 40–60% ammo-
nium sulfate fraction is not known, but those results
suggest that another factor plays a critical role in the
commitment of this pre-mRNA to spliceosome assem-
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bly+ This system may be reminiscent of the Drosophila
dsx system whereby Tra/Tra2 and SR proteins interact
with ESEs and thereby promote upstream 39 splice site
usage (Tian & Maniatis, 1993)+ There is the possibility
that the hTra2 proteins may be the additional compo-
nent, along with S100 1 SR, to activate p4d55 splicing+
It is also interesting to note that unlike the 39 splice site,
the 59 splice site of exon 6 can be spliced in the pres-
ence of S100 1 SR proteins (Tsukahara et al+, 1994)+
Thus, different subsets of factors participate in the use
of the 39 and 59 splice sites of this exon+
ESEs and their role in exon definition
Most higher eukaryotic pre-mRNAs are characterized
by having short exons and very long introns+ In these
cases recognition of splice sites in an intronic polarity
becomes implausible and models proposing recogni-
tion in an exonic polarity combined with experimental
evidence that promotes such models have become es-
tablished (Robberson et al+, 1990; Berget, 1995)+ In
such a situation, a weak splice site on one side of an
exon can have an adverse effect on the removal of the
intron on the other side or, alternatively, a strong splice
site on one side of an exon can promote the removal of
the intron on the other side+ It was shown experimen-
tally that a strong 59 splice site improves upstream 39
splice site usage correlating U1 snRNP and U2AF bind-
ing to these sites (Hoffman & Grabowski, 1992)+ Fur-
thermore, exonic sequences were shown to play a role
in similar situations (Staknis & Reed, 1994)+ We show
here, using the sequences around exon 6 as a model
substrate, that ESEs play a role in both upstream and
downstream intron removal when either splice site flank-
ing exon 6 is suboptimal+ When both the 39 and 59
splice site around exon 6 are strong, however, ESEs
seem to be dispensable towards splice site usage+
These results have implications about regulation of
usage of alternatively spliced exons+ It is a common
feature of constitutively spliced exons to have strong
splice sites, thereby eliminating the requirement for other
cis elements+ In the case of alternatively spliced exons,
splice sites are often weak, leading to exon exclusion+
We show that cis elements that lie within the exon pro-
mote communication of the splice sites flanking the exon
within which they reside, thus allowing their inclusion+
Further work will be required to fully characterize the
role of the ESEs identified in this study+ Which se-
quences in exon 8 are involved in the splicing of exon 6
to 8 (fibroblast-type splice) or exon 7 to 8 (skeletal
muscle-type splice) are not known+ It will be important
to determine whether the same cis-acting elements
and SR proteins mediate these splicing events in non-
muscle and muscle environments+ Such differences
might play a critical role in regulation of tissue-specific
alternative RNA splicing, and experiments are currently
in progress to address these questions+
MATERIALS AND METHODS
Plasmid construction: SP6-p4d55 series
of mutants
Substrates used are the same as described in Tsukahara
et al+ (1994)+ Mutations to the purine-rich motifs in these sub-
strates were made by using oligonucleotides and PCR+ Oli-
gonucleotides used to create p4d556-1, p4d556-2, p4d558-1,






CTGAAGGAGGCTGAG-39+The mutated fragments were then
subcloned into the original SP6-p4d55 parental vector+
To create the p2p6(8/9) series of mutants, oligonucleo-
tides to 6-1 and 6-2 (see above) were used in the parental
constructs described in Tsukahara et al+ (1994)+ The SV40p2
minigene used for transfection was the same as described in
Guo & Helfman (1993)+To create the substrates SV40p2(6-1),
SV40p2(6-2),SV40p2(6-1/2),SV40p2pU(6-1),SV40p2pU(6-
2), and SV40p2pU(6-1/2) we subcloned a Bsu361 fragment
from the p2p6(8/9)6-1,p2p6(8/9)6-2,p2p6(8/9)6-1/2,p2p6(8/
9)pU6-1, p2p6(8/9)pU6-2, p2p6(8/9)pU6-1/2, respectively,
into an SV40p2 plasmid+
In vitro transcription
For the in vitro splicing assays, 32P-labeled SP6-tropomyosin
pre-mRNAs (linearized at ClaI) were synthesized in vitro
(primed with m7CAP analog) as described in Tsukahara et al+
(1994)+ RNA used for spliceosome assembly was synthe-
sized in the presence of all four radiolabeled nucleotides and
gel purified+ RNA used as competitor for competition exper-
iments was synthesized similarly, but without the addition of
radiolabeled nucleotides, following which it was gel purified+
RNA used for UV crosslinking was synthesized similarly, but
in the presence of all four radiolabeled nucleotides and in
addition they were gel purified+ RNA used for competition
experiments was synthesized similarly, but without the addi-
tion of radiolabeled nucleotides, following which it was gel
purified+
p2p6(8/9) templates used for in vitro transcription were
linearized at the BamHI site at the end of exon 9+ The same
series of plasmids was also used to obtain templates for the
p5 series (exon 5-intron 5-exon 6) but were linearized with
StuI, which recognizes a site 19 nt downstream of exon 6+
The plasmids in the Dp2p6(8/9) series were linearized at the
BamHI site at the end of exon 9 to provide templates for in
vitro transcription+
In vitro splicing
HeLa cell nuclear extracts were prepared as described (Dig-
nam et al+, 1983)+ In vitro splicing reactions were carried out
at 30 8C for 120 min or as indicated+ Standard reactions con-
tained 60% nuclear extract, 2 mM MgCl2, 500 mM ATP,
20 mM creatine phosphate, 2+6% (w/v) polyvinyl alcohol,
15–30 ng 32P-labeled pre-mRNA, 13 mM HEPES (pH 8+0),
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12% (v/v) glycerol, 60 mM KCl, 0+12 mM EDTA, and 0+3 mM
DTT in a reaction volume of 25 mL+ After incubation for the
indicated time, the reactions were stopped by the addition of
SDS and proteinase K+ The RNA was recovered as described
(Krainer et al+, 1984)+ The products of the reaction were an-
alyzed on 4% acrylamide/7 M urea gels+ For competition
experiments, unlabeled RNA competitor was preincubated
with the nuclear extract for 15 min prior to the addition of
32P-labeled pre-mRNA and ATP/CP containing mix+
Spliceosome assembly
We use the method of Konarska and Sharp (1986) but PVA
was added at a concentration of 0+5% (final concentration)
per reaction+ Briefly, substrate pre-mRNA (radiolabeled with
all 4 nt) was incubated with nuclear extract and ATP/CP mix+
After an incubation at the indicated time points at 30 8C, the
reaction was loaded directly onto a 8:1 nondenaturing Tris-
Gly gel system+
Protein preparations
Nuclear extract was prepared as described above+ SR pro-
teins were prepared as described by Zahler et al+ (1992)+
SF2/ASF was a gift of Dr+ Mike Murray+ SC35 was a gift of
Dr+ Hong-Xiang Liu+ Several SR preparations were a gift of
Dr+Akila Mayeda (Krainer et al+, 1990b; Screaton et al+, 1995)+
S100 was a gift from Charlie Chen (Mayeda & Krainer, 1992)+
UV crosslinking
32P-labeled RNA probe was incubated with the indicated
amounts of protein in a final volume of 12+5 mL containing
2 mM MgCl2, 500 mM ATP, 20 mM creatine phosphate, 1+3 mg
tRNA and 400 ng BSA+ The reactions were incubated at 30 8C
for 10 min and irradiated with UV light (254 nm at a distance
of 7 cm) for 5 min after which Rnase A and RNase T1 were
added to a final concentration of 1 mg/mL and 2 U/mL, re-
spectively, and incubated at 37 8C for 15 min+ Laemmli sam-
ple buffer was then added, and the samples were boiled
before loading on a 12% SDS-PAGE gel+
Derivation of score matrix
The derivation of the score matrix is as described in Liu et al+
(1998)+
Transfections and preparation of mRNA
HeLa cells were transfected with the different SV40-p2 con-
structs using the calcium phosphate precipitation protocol
(see Helfman et al+, 1990, for transfection details)+
To harvest total cytoplasmic RNA, cells were washed
in cold PBS and scraped off in 1 mL of PBS/plate+ Cells
were pelleted and resuspended in 350 mL cold lysis buffer
(150 mM NaCl, 1+5 mM MgCl, 10 mM Tris-Cl [pH 8+0],
200 U/mL RNasin) and NP40 was added to a final concen-
tration of 0+5%+ After an incubation on ice for 5 min, the
samples were spun at 4 8C+ The supernatant was transferred
to a fresh tube containing 4 mL of 20% SDS, mixed, and 5 mL
of proteinase K (10 mg/mL) were added, and the entire re-
action was incubated at 37 8C for 15 min+ The samples were
extracted with equal volumes of phenol-chloroform (23) and
chloroform (13)+ Samples were precipitated with 40 mL 3 M
NaOAc and 1 mL EtOH+ Pellets were washed with 75% EtOH,
25% 0+1 M NaOAc and resuspended in 50 mL of 23 DNase
buffer (20 mM MgCl, 2 mM DTT), 1 mL RNasin, and 3 mL
DNase, and incubated at 37 8C for 20 min+ Twenty-five mi-
croliters of DNase stop solution (2+5 M NaOAc, 0+1 M EDTA)
were added and the samples were once again extracted and
precipitated as described above+ Dried pellets were resus-
pended in DEPC water and ODs were taken+
RT-PCR
cDNA was made in a reverse transcription reaction as fol-
lows: 400 ng of total RNA were boiled for 3 min with 250 pmol
of oligo dT and then incubated at 42 8C for 120 min in a
reaction volume of 30 mL containing 10 mM DTT, 500 mM
dNTPs, RT buffer, and RT superscript+ Six microliters of this
cDNA mixture were then used as template in a 50 mL PCR
reaction containing 40 mM dNTPs, 1+5 mM MgCl, Taq buffer,
Taq polymerase, and 20 pmol each of forward and reverse
primer+ Primers used to analyze the spliced products of the
b-TM minigene are: (1) 59 TTTTGGAGGCCTAGGCTTTT 39,
homologous to the SV40 leader sequences; (2) 59 CACCTC
GGCTCTCTC 39, complementary to exon 5 sequences of
b-TM; and (3) 59 TTTGCCACAGATCTTTCAGC 39, comple-
mentary to exon 9 sequences of b-TM+ The PCR reactions
underwent 25 cycles at 94 8C for 45 s, 55 8C for 1 min, and
72 8C for 1 min followed by an extension at 72 8C for 10 min+
An aliquot of each sample was digested with Nco1, which
allows for clear distinction between exon 6 versus exon 7
usage, and analyzed by agarose gel electrophoresis and
stained with ethidium bromide, following which they were
photographed+
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